product summary
company name :
Developmental Studies Hybridoma Bank
product type :
antibody
product name :
KI-67; Marker of proliferation Ki-67
catalog :
AFFN-KI67-3E6
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
AFFN-KI67-3E6
reactivity :
human
application :
ELISA, immunocytochemistry
more info or order :
citations: 3
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
Taussig M, Stoevesandt O, Borrebaeck C, Bradbury A, Cahill D, Cambillau C, et al. ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods. 2007;4:13-7 pubmed
|
product information
Internal ID :
13563
Name :
AFFN-KI67-3E6
Depositor Name :
EU Program Affinomics
Depositor Institution :
EMBL MACF
Depositor Website :
http://www.proteinbinders.org
Date Deposited :
12/3/14
Allow Hybridoma Distribution :
No
Cells Available (legacy) :
No
Antigen :
KI-67; Marker of proliferation Ki-67
Antigen Species :
Human
Host Species :
mouse
Isotype :
MIgG2b
Positive Tested Species Reactivity :
Human
Initial Publication Pubmed ID :
21572409 17195019
Depositor Notes (Special Instructions) :
This antibody recognizes a nuclear protein that may be required for cell proliferation.
Collections :
Human,Nucleus
Search Keywords :
EU Program Affinomics, KI-67; Marker of proliferation Ki-67, Human, MIgG, Human, MKI67, MIB-1, , Monoclonal
Antigen Molecular Weight :
358.6 kDa
Gene :
MKI67
Alternate Gene Name(s) :
MIB-1
Uniprot ID :
P46013
Antibody Registry ID :
AB_2617702
Immunogen :
Recombinant peptide
Immunogen Sequence :
a.a. 1-102
Clonality :
Monoclonal
Myeloma Strain :
SP2/0-AG14
Epitope Mapped :
Yes
Recommended Applications :
ELISA,Immunofluorescence,Microarray
Immunofluorescence Pubmed IDs :
27678304
Depositor Growth Medium :
High glucose DMEM +20% FBS + 1% glutamine plus pen-strep
Additional Information :
RRID:AB_2617702
DSHB Growth Medium :
Iscove's
more info or order :
company information
Developmental Studies Hybridoma Bank
review
product type
browse more products
questions and comments